Nature of the Event
Vijaya Diagnostic Centre Limited has intimated the National Stock Exchange of India Limited (NSE Symbol: VIJAYA) and BSE Limited (BSE Scrip Code: 543350) about an upcoming earnings conference call for analysts and investors. This disclosure is made pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Event Date and Time
The earnings conference call is scheduled for Friday, August 7, 2026, at 10:30 A.M. Indian Standard Time (IST).
Purpose of the Call
The conference call will discuss the financial results of the company for the first quarter ended June 30, 2026 (Q1 FY27).
Company Participants
The following management representatives from Vijaya Diagnostic Centre Limited will participate in the call:
- Ms. Suprita Reddy (Managing Director & Chief Executive Officer)
- Mr. Siva Rama Raju Vegesna (Chief Operating Officer - COO)
- Mr. Narasimha Raju (Chief Financial Officer - CFO)
- Mr. Dhiren Gala (Head – Investor Relations & Corporate Development)
Call Access Information
JM Financial Institutional Securities Limited is organizing the conference call. Dial-in details are provided for multiple regions:
- India: +91 22 6280 1366 or +91 22 7115 8267
- USA Toll-free: 1 866 746 2133
- UK Toll-free: 0 808 101 1573
- Singapore Toll-free: 800 101 2045
- Hong Kong Toll-free: 800 964 448
Participants are advised to dial in 10 minutes prior to the conference schedule to ensure timely connection.
Additional Contacts
For further information, participants can contact:
- Mr. Amey Chalke: +91 9664976620, amey.chalke@jmfl.com
- Mr. Abin Benny: +91 7710066464, abin.benny@jmfl.com
Forward-Looking Statements Disclaimer
The document includes a safe harbor statement noting that the management discussion may include forward-looking statements subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those contemplated.